Replies to post #49 on Provention Bio, Inc. (PRVB)

[sokol]

Great news! I wonder if the FDA included some limitations in its approval. The stock is trading again after hours, but it has not jumped like I expected it would upon approval. Anyway, I think it will wind up being broadly prescribed for diabetes patients. Thanks